Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeffrey Runge Insider Profile
4 Followers
Jeffrey Runge, Director at Altimmune, holds 12.50K shares in Aditxt, Inc. (Ticker: ADTX), holds 37.85K shares in Altimmune (Ticker: ALT). Most recently, Jeffrey Runge Bought ― shares of Aditxt, Inc. on Jun 02, 2021 for an estimated value of 29.31K.
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-54.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Jeffrey Runge
Jeffrey Runge's Trading History
Altimmune
Jan 24, 2017
Director
Informative Buy
62.20K
$295.99K
Aditxt, Inc.
Jun 02, 2021
Director
Informative Buy
29.31K
$27.50K
List of latest transactions for each holding click on a transaction to see Jeffrey Runge's performance on stock
You May Also Like
Jeffrey Runge insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Runge?
The percentage of profitable transactions made by Jeffrey Runge is 0%.
What is the average return per transaction made by Jeffrey Runge?
The average return per transaction made by Jeffrey Runge is -54.50%.
What stocks does Jeffrey Runge hold?
Jeffrey Runge holds: ALT, ADTX stocks.
What was Jeffrey Runge’s latest transaction?
Jeffrey Runge latest transaction was an Informative Buy of $29.31K.
What was Jeffrey Runge's most profitable transaction?
Jeffrey Runge’s most profitable transaction was an Informative Buy of ALT stock on September 19, 2016. The return on the trade was -27.20%.
What is Jeffrey Runge's role in Altimmune?
Jeffrey Runge's role in Altimmune is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.